Compounded semaglutide vs brand name Wegovy: what is the real difference?

Short answer

• The active drug (semaglutide) can be the same in both, but Wegovy (Novo Nordisk) is an FDA‑approved, factory-made product with demonstrated safety, efficacy, and consistent quality. Compounded semaglutide is made by a pharmacy for an individual patient and carries more variability and regulatory/quality differences.

Key differences

1. Regulation and manufacturing

• Wegovy (Novo Nordisk): manufactured under FDA oversight and Good Manufacturing Practices (GMP). Doses, stability, sterility, and device performance were tested in clinical trials.
• Compounded semaglutide: made by a compounding pharmacy under state board rules and USP standards (if followed). Compounding pharmacies aren’t FDA‑approved manufacturers; oversight is different and quality can vary by pharmacy.

1. Evidence and labeling

• Wegovy: approved specifically for chronic weight management at the labeled dosing schedule (started and titrated exactly as in trials). Its safety and efficacy for weight loss were proven in large randomized trials.
• Compounded semaglutide: the active molecule may be identical, but compounded versions generally don’t have the same clinical-trial data, and formulations/doses may differ from the Wegovy regimen.

1. Formulation, stability and devices

• Wegovy: comes in prefilled pens designed for the approved dosing steps and stability handled by the manufacturer.
• Compounded products: may be supplied in vials, syringes, or custom pens. Stability, preservatives, excipients, and sterility can differ, which affects potency and infection risk. Dosing errors are also more likely if the delivery device differs.

1. Quality control and safety reporting

• Wegovy: batch testing, traceability, and mandatory drug‑safety reporting to FDA.
• Compounded: quality depends on the pharmacy; not subject to the same batch testing and post‑market surveillance. Reporting of adverse events is possible but less systematic.

1. Cost and access

• Wegovy is often expensive and may or may not be covered by insurance, but manufacturer savings programs exist (Novo Nordisk patient support).
• Compounded semaglutide is frequently cheaper and more accessible but with the tradeoff of variable quality and potential legal/insurance issues.

1. Legal and ethical considerations

• Some compounding pharmacies may compound from bulk active pharmaceutical ingredient (API) sources of uncertain origin—this raises the risk of counterfeit, contamination, or inaccurate dosing. Avoid products sourced from unverified suppliers or online black markets.

When a compounded product might be reasonable

• If Wegovy is unaffordable or unavailable, using compounded semaglutide from a reputable, accredited compounding pharmacy can be considered—but only after careful vetting: PCAB accreditation (or state-licensed, USP compliance), written sterility testing/Certificate of Analysis (COA) for each lot, clear instructions and compatible delivery devices, and a prescriber who monitors you.

What to ask a compounding pharmacy before using their semaglutide

• Are you PCAB-accredited or compliant with USP <795/797/800> standards?
• Can you provide a Certificate of Analysis showing potency and sterility testing for the lot?
• What source is used for the active ingredient (API)? Is it FDA‑approved or from a verified supplier?
• How is it stored and what device is provided for dosing?
• What are the documented stability and expiration dating?

Recommendations (specific names/services)

• Wegovy (Novo Nordisk) — the evidence-backed, FDA‑approved choice for weight management; best for predictable quality and safety.
• Ozempic or Rybelsus (Novo Nordisk) — other brand semaglutide formulations (Ozempic is injectable for diabetes; Rybelsus is oral) sometimes used clinically by providers for metabolic effects but are different labeled doses/indications.
• If cost is the barrier: contact Novo Nordisk patient support (NovoCare) and check GoodRx or Blink Health for coupons/discounts before opting for a compounded product.
• If you consider compounding: use a PCAB‑accredited compounding pharmacy and get written COAs and sterility testing results before you accept product.

Bottom line Wegovy offers reliable, trial‑proven dosing, manufacturing quality, and regulatory oversight. Compounded semaglutide can be less costly or more accessible but has greater variability in quality, dosing, stability, and safety oversight — so only use it from a highly reputable, accredited compounding pharmacy and under close medical supervision.

If you want, tell me whether your main concern is cost, availability, or device preference and I can suggest next steps (e.g., manufacturer assistance programs, how to verify a compounding pharmacy, or how to discuss options with your prescriber).